GILD acquires KITE for $180/share, cash, $11.9B. My question: Does MSKCC work with PPHM in CAR-T improvement offer further potential in this arena once human clinical trials are entered?
"One has to agree with these puzzle pieces and again, all this does not mean I back the current BOD 100% as I have to see better game plan on that side as well. As of now, I want a 3rd option if all stays the same with current choices so yes...I am picky for sure."
The game is to split the retail vote knowing dam well the current BOD has a competitive number of votes in the bag as it stands. There likely will be new names on the ticket. The current takers have planned for everything in their entrenchment strategy. Every vote taken away from Ronin's group helps solidify the current BOD's win. All in my opinion but that sure does seem to be the strategy. We will have to see how the voting works when time comes. All retailers that want change will need to vote consistently to ensure a win for change. Split the vote and we risk status quo continuing. Again all in my opinion.
Market Data 
Markets 
AI
